UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care

Journal of viral hepatitis, 2017-04, Vol.24 (4), p.262-267

2017

Volltextzugriff (PDF)

Sofosbuvir‐based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt

Alimentary pharmacology & therapeutics, 2017-03, Vol.45 (5), p.681-687

2017

Volltextzugriff (PDF)

Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies

Alimentary pharmacology & therapeutics, 2015-09, Vol.42 (6), p.696-706

2015

Volltextzugriff (PDF)

Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real‐world results from 18 378 patients in Egypt

Alimentary pharmacology & therapeutics, 2018-02, Vol.47 (3), p.421-431

2018

Volltextzugriff (PDF)

Editorial: is sofosbuvir‐based therapy suitable for patients with advanced chronic kidney disease?

Alimentary pharmacology & therapeutics, 2018-08, Vol.48 (3), p.379-380

2018

Volltextzugriff (PDF)

Estimating HCV disease burden—volume 4 (editorial)

Journal of viral hepatitis, 2017-11, Vol.24 (S2), p.4-7

2017

Volltextzugriff (PDF)

Does transcutaneous electrical nerve stimulation have an antipruritic effect in lichen planus? A randomized clinical trial

Clinical and experimental dermatology, 2019-04, Vol.44 (3), p.252-256

2019

Volltextzugriff (PDF)

Association of the polymorphism of the Toll‐like receptor (TLR)‐3 and TLR‐9 genes with hepatitis C virus‐specific cell‐mediated immunity outcomes among Egyptian health‐care workers

Clinical and experimental immunology, 2021-01, Vol.203 (1), p.3-12

2021

Volltextzugriff (PDF)

PALBI - the platelet-albumin-bilirubin score – a better predictor of outcome of acute variceal bleeding

Journal of hepatology, 2017, Vol.66 (1), p.S564-S564

2017

Volltextzugriff (PDF)

Simeprevir plus sofosbuvir for eight or 12 weeks in treatment‐naïve and treatment‐experienced hepatitis C virus genotype 4 patients with or without cirrhosis

Journal of viral hepatitis, 2017-02, Vol.24 (2), p.102-110

2017

Volltextzugriff (PDF)

MIR-155: A Double Faced Microrna with Respect to its Impact on Tumorigenesis in both Natural Killer Cells and their Target Hepatocytes

Journal of hepatology, 2016, Vol.64 (2), p.S518-S519

2016

Volltextzugriff (PDF)

Let-7a; A Single Microrna with Opposing Cell-Specific-Tumorigenic Action in both Natural Killer Cells and their Target Hepatocytes

Journal of hepatology, 2016, Vol.64 (2), p.S508-S508

2016

Volltextzugriff (PDF)

Prevalence of thyroid dysfunction among 21672 Egyptian patients with chronic HCV genotype IV

Journal of hepatology, 2017, Vol.66 (1), p.S703-S704

2017

Volltextzugriff (PDF)

Validation of the role of FIB-4 and APRI in the assessment of hepatic fibrosis and prediction of risky varices in Egyptian patients with chronic hepatitis C (genotype 4)

Journal of hepatology, 2017, Vol.66 (1), p.S705-S705

2017

Volltextzugriff (PDF)

microRNA-34a and natural killer cells: an immuno-epigenetic approach to halt hepatocellular carcinoma progression

Journal of hepatology, 2017, Vol.66 (1), p.S231-S232

2017

Volltextzugriff (PDF)

Competition Law and Policy in the Global South: Power, Coercion and Distribution

Current legal problems, 2023-11, Vol.76 (1), p.375-402

Waked, Dina I

2023

Volltextzugriff (PDF)

P533 TRANSIENT ELASTOGRAPHY CAN PREDICT HEPATIC DECOMPENSATION IN PATIENTS WITH CHRONIC HEPATITIS C

Journal of hepatology, 2014-04, Vol.60 (1), p.S247-S247

2014

Volltextzugriff (PDF)

Spontaneous Regression of HCC: A Case Report

Clinical gastroenterology and hepatology, 2015-07, Vol.13 (7), p.e112-e112

2015

Volltextzugriff (PDF)

Restoring the Expression of Endogenous IGF-1 by MIR-486 in NK Cells of HCC Patients Augments its Cytotolytic Activity against Hepatoma Cell Lines

Journal of hepatology, 2016, Vol.64 (2), p.S522-S522

2016

Volltextzugriff (PDF)

P1025 UTILITY OF TRANSIENT ELASTOGRAPHY AND NON-INVASIVE FIBROSIS INDICES IN ASSESSING CHANGES IN FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C

Journal of hepatology, 2014-04, Vol.60 (1), p.S416-S416

2014

Volltextzugriff (PDF)

P1351 : An open-label study to evaluate the efficacy and safety of co-formulated ombitasvir/paritaprevir/ritonavir with ribavirin in adults with chronic HCV genotype 4 infection in Egypt

Journal of hepatology, 2015-04, Vol.62, p.S863-S864

2015

Volltextzugriff (PDF)

P0482 : Improving natural killer cells cytotoxicty and harnessing hepatocyte cancer progression by MIR-486-5P

Journal of hepatology, 2015-04, Vol.62, p.S495-S495

2015

Volltextzugriff (PDF)

Efficacy and Safety of Direct Acting Antiviral Therapy for HCV Genotype 4 in Egypt; Multicenter Real Life Experience

Journal of hepatology, 2016, Vol.64 (2), p.S791-S792

2016

Volltextzugriff (PDF)

Ombitasvir/Paritaprevir/Ritonavir with Ribavirin Achieves High Sustained Virologic Response (SVR) Rates in Egyptian Adults with Chronic HCV Genotype 4 Infection (Agate-II)

Journal of hepatology, 2016, Vol.64 (2), p.S772-S772

2016

Volltextzugriff (PDF)

Real-Life Results of Sofosbuvir Based Therapy for Egyptian Patients with Hepatitis C and Advanced Fibrosis-Cirrhosis

Journal of hepatology, 2016, Vol.64 (2), p.S772-S772

2016

Volltextzugriff (PDF)

1 – 25 von 863

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(698)
Mit Volltextzugriff
(652)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(20)
... seit 30 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care

Sofosbuvir‐based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt

Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies

Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real‐world results from 18 378 patients in Egypt

Editorial: is sofosbuvir‐based therapy suitable for patients with advanced chronic kidney disease?

Estimating HCV disease burden—volume 4 (editorial)

Does transcutaneous electrical nerve stimulation have an antipruritic effect in lichen planus? A randomized clinical trial

Association of the polymorphism of the Toll‐like receptor (TLR)‐3 and TLR‐9 genes with hepatitis C virus‐specific cell‐mediated immunity outcomes among Egyptian health‐care workers

PALBI - the platelet-albumin-bilirubin score – a better predictor of outcome of acute variceal bleeding

Simeprevir plus sofosbuvir for eight or 12 weeks in treatment‐naïve and treatment‐experienced hepatitis C virus genotype 4 patients with or without cirrhosis

MIR-155: A Double Faced Microrna with Respect to its Impact on Tumorigenesis in both Natural Killer Cells and their Target Hepatocytes

Let-7a; A Single Microrna with Opposing Cell-Specific-Tumorigenic Action in both Natural Killer Cells and their Target Hepatocytes

Prevalence of thyroid dysfunction among 21672 Egyptian patients with chronic HCV genotype IV

Validation of the role of FIB-4 and APRI in the assessment of hepatic fibrosis and prediction of risky varices in Egyptian patients with chronic hepatitis C (genotype 4)

microRNA-34a and natural killer cells: an immuno-epigenetic approach to halt hepatocellular carcinoma progression

Competition Law and Policy in the Global South: Power, Coercion and Distribution

P533 TRANSIENT ELASTOGRAPHY CAN PREDICT HEPATIC DECOMPENSATION IN PATIENTS WITH CHRONIC HEPATITIS C

Spontaneous Regression of HCC: A Case Report

Restoring the Expression of Endogenous IGF-1 by MIR-486 in NK Cells of HCC Patients Augments its Cytotolytic Activity against Hepatoma Cell Lines

P1025 UTILITY OF TRANSIENT ELASTOGRAPHY AND NON-INVASIVE FIBROSIS INDICES IN ASSESSING CHANGES IN FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C

P1351 : An open-label study to evaluate the efficacy and safety of co-formulated ombitasvir/paritaprevir/ritonavir with ribavirin in adults with chronic HCV genotype 4 infection in Egypt

P0482 : Improving natural killer cells cytotoxicty and harnessing hepatocyte cancer progression by MIR-486-5P

Efficacy and Safety of Direct Acting Antiviral Therapy for HCV Genotype 4 in Egypt; Multicenter Real Life Experience

Ombitasvir/Paritaprevir/Ritonavir with Ribavirin Achieves High Sustained Virologic Response (SVR) Rates in Egyptian Adults with Chronic HCV Genotype 4 Infection (Agate-II)

Real-Life Results of Sofosbuvir Based Therapy for Egyptian Patients with Hepatitis C and Advanced Fibrosis-Cirrhosis

Suchergebnisse filtern